|
DE286354C
(https=)
|
|
|
|
|
|
JPS6140270A
(ja)
|
1984-08-01 |
1986-02-26 |
Morishita Seiyaku Kk |
ピリダジノン誘導体
|
|
ES2131506T3
(es)
|
1990-09-21 |
1999-08-01 |
Rohm & Haas |
Dihidropiridacinonas y piridacinonas como fungicidas.
|
|
US6334997B1
(en)
|
1994-03-25 |
2002-01-01 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
|
CN1087725C
(zh)
|
1994-03-25 |
2002-07-17 |
同位素技术有限公司 |
用氘代方法增强药物效果
|
|
IL118631A
(en)
|
1995-06-27 |
2002-05-23 |
Tanabe Seiyaku Co |
History of pyridazinone and processes for their preparation
|
|
DE19629817A1
(de)
|
1996-07-24 |
1998-01-29 |
Hoechst Ag |
Neue Imino-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
|
|
NZ522882A
(en)
|
2000-06-05 |
2004-07-30 |
Altana Pharma Bv |
Pyridazinone compounds effective as beta-2-adrenoreceptor agonists as well as PDE4-inhibitors
|
|
US20040067955A1
(en)
*
|
2002-09-06 |
2004-04-08 |
Fujisawa Pharmaceutical Co. Ltd. |
Pyridazinone compound and pharmaceutical use thereof
|
|
CN1326852C
(zh)
|
2003-03-07 |
2007-07-18 |
兴和株式会社 |
苯并呋喃衍生物
|
|
JP4890439B2
(ja)
|
2005-03-07 |
2012-03-07 |
杏林製薬株式会社 |
ピラゾロピリジン−４−イルピリダジノン誘導体とその付加塩及びそれらを有効成分とするｐｄｅ阻害剤
|
|
WO2007044796A2
(en)
|
2005-10-11 |
2007-04-19 |
Nps Pharmaceuticals, Inc. |
Pyridazinone compounds as calcilytics
|
|
DE102005057924A1
(de)
|
2005-12-05 |
2007-06-06 |
Merck Patent Gmbh |
Pyridazinonderivate
|
|
UA95644C2
(ru)
|
2006-07-25 |
2011-08-25 |
Сефалон, Инк. |
Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний
|
|
AU2008219166B2
(en)
|
2007-02-16 |
2013-05-16 |
Amgen Inc. |
Nitrogen-containing heterocyclyl ketones and their use as c-Met inhibitors
|
|
DE102007025718A1
(de)
|
2007-06-01 |
2008-12-04 |
Merck Patent Gmbh |
Pyridazinonderivate
|
|
DE102007025717A1
(de)
|
2007-06-01 |
2008-12-11 |
Merck Patent Gmbh |
Arylether-pyridazinonderivate
|
|
DE102007032507A1
(de)
|
2007-07-12 |
2009-04-02 |
Merck Patent Gmbh |
Pyridazinonderivate
|
|
GB0715087D0
(en)
*
|
2007-08-03 |
2007-09-12 |
Summit Corp Plc |
Drug combinations for the treatment of duchenne muscular dystrophy
|
|
DE102007038957A1
(de)
|
2007-08-17 |
2009-02-19 |
Merck Patent Gmbh |
6-Thioxo-pyridazinderivate
|
|
DE102008019907A1
(de)
|
2008-04-21 |
2009-10-22 |
Merck Patent Gmbh |
Pyridazinonderivate
|
|
WO2009142732A2
(en)
*
|
2008-05-20 |
2009-11-26 |
Cephalon, Inc. |
Substituted pyridazinone derivatives as histamine-3 (h3) receptor ligands
|
|
WO2010048149A2
(en)
|
2008-10-20 |
2010-04-29 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
|
AR081331A1
(es)
|
2010-04-23 |
2012-08-08 |
Cytokinetics Inc |
Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
|
|
AR081626A1
(es)
*
|
2010-04-23 |
2012-10-10 |
Cytokinetics Inc |
Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
|
|
WO2012021707A2
(en)
|
2010-08-11 |
2012-02-16 |
The Regents Of The University Of California |
Premature-termination-codons readthrough compounds
|
|
BR112013007499A2
(pt)
|
2010-09-01 |
2016-07-12 |
Genentech Inc |
piridazinonas - métodos de criação e usos
|
|
US8759380B2
(en)
|
2011-04-22 |
2014-06-24 |
Cytokinetics, Inc. |
Certain heterocycles, compositions thereof, and methods for their use
|
|
WO2013057101A1
(de)
|
2011-10-17 |
2013-04-25 |
Bayer Intellectual Property Gmbh |
Substituierte oxadiazolylpyridinone und - pyridazinone als hif - hemmer
|
|
CN103570730A
(zh)
|
2012-08-01 |
2014-02-12 |
中国科学院上海药物研究所 |
具有桥环结构的稠环哒嗪酮类化合物及其制备方法和用途
|
|
US20140073634A1
(en)
|
2012-08-24 |
2014-03-13 |
Institute For Applied Cancer Science/The University of Texas MD Anderson Cancer Center |
Heterocyclic modulators of hif activity for treatment of disease
|
|
US9566310B2
(en)
|
2012-09-10 |
2017-02-14 |
Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Reno |
Methods of treating muscular dystrophy
|
|
US9216180B2
(en)
|
2012-10-02 |
2015-12-22 |
New York University |
Pharmaceutical compositions and treatment of genetic diseases associated with nonsense mediated RNA decay
|
|
AU2013365926B9
(en)
|
2012-12-21 |
2019-01-17 |
Zenith Epigenetics Ltd. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
EP2953944B1
(en)
|
2013-02-07 |
2017-04-26 |
Merck Patent GmbH |
Pyridazinone-amides derivatives
|
|
MX365950B
(es)
|
2013-03-13 |
2019-06-19 |
Flatley Discovery Lab Llc |
Compuestos de piridazinona y metodos para el tratamiento de la fibrosis quistica.
|
|
WO2014189634A1
(en)
*
|
2013-04-19 |
2014-11-27 |
University Of Iowa Research Foundation |
Angiotensins in muscular dystrophy
|
|
US10555960B2
(en)
*
|
2015-06-05 |
2020-02-11 |
Ptc Therapeutics, Inc. |
Use of an aminoglycoside for nonsense mutation suppression and the treatment of disease
|
|
JP7007199B2
(ja)
*
|
2015-06-10 |
2022-02-10 |
アソシアシオン・アンスティテュ・ドゥ・ミオロジー |
デュシェンヌ型筋ジストロフィーのための併用療法
|
|
CN106467495A
(zh)
|
2015-08-19 |
2017-03-01 |
中国科学院上海药物研究所 |
哒嗪酮类化合物、其制备方法、药物组合物及用途
|
|
WO2017046117A1
(en)
|
2015-09-15 |
2017-03-23 |
Abbvie Inc. |
Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of use
|
|
AU2017348186A1
(en)
|
2016-10-26 |
2019-05-16 |
Proteostasis Therapeutics, Inc |
Pyridazine derivatives, compositions and methods for modulating CFTR
|
|
CA3041675A1
(en)
|
2016-10-26 |
2018-05-03 |
Proteostasis Therapeutics, Inc. |
N-phenyl-2-(3-phenyl-6-oxo-1,6-dihydropyridazin-1-yl)acetamide derivatives for treating cystic fibrosis
|
|
WO2018081378A1
(en)
*
|
2016-10-26 |
2018-05-03 |
Proteostasis Therapeutics, Inc. |
Compounds, compositions, and methods for modulating cftr
|
|
EP3600322A1
(en)
|
2017-03-28 |
2020-02-05 |
Boehringer Ingelheim International GmbH |
Nintedanib for use in methods for the treatment of muscular dystrophy
|
|
TWI902102B
(zh)
|
2017-04-06 |
2025-10-21 |
美商富曼西公司 |
殺真菌之噁二唑
|
|
US20180303821A1
(en)
|
2017-04-24 |
2018-10-25 |
BraneQuest, Inc. |
Membrane active molecules
|
|
BE1025518B1
(fr)
|
2017-08-30 |
2019-04-03 |
E2 Drives Sa |
Groupe motopropulseur
|
|
JP2020533316A
(ja)
*
|
2017-09-06 |
2020-11-19 |
トランスレイショナル・ドラッグ・ディベロップメント・エルエルシー |
アミノベンゾイミダゾール誘導体、治療、およびヒストン脱アセチル化酵素を阻害する方法
|
|
EP3700516B1
(en)
|
2017-10-27 |
2024-01-24 |
Sonic Master Limited |
Inhibitors of dux4 induction for regulation of muscle function
|
|
CN112166181B
(zh)
|
2018-05-17 |
2024-03-08 |
保尔特纺织品公司 |
用于改善重组蛋白分泌的sec经修饰菌株
|
|
EP4685140A1
(en)
|
2018-06-04 |
2026-01-28 |
Ohio State Innovation Foundation |
Eaat2 activators and methods of using thereof
|
|
EP3828174A4
(en)
|
2018-07-19 |
2022-08-17 |
Sumitomo Pharma Co., Ltd. |
PYRIDAZINONE DERIVATIVE
|
|
CN108947912B
(zh)
|
2018-07-31 |
2021-10-01 |
中国人民解放军总医院 |
一种靶向Neddylation通路的抗肿瘤化合物
|
|
CA3118908A1
(en)
*
|
2018-11-06 |
2020-05-14 |
Edgewise Therapeutics, Inc. |
Pyridazinone compounds and uses thereof
|
|
AU2019374812B2
(en)
|
2018-11-06 |
2025-03-06 |
Edgewise Therapeutics, Inc. |
Pyridazinone compounds and uses thereof
|
|
DK3877376T3
(da)
|
2018-11-06 |
2023-10-02 |
Edgewise Therapeutics Inc |
Pyridazinonforbindelser og anvendelser deraf
|
|
EP4149621B1
(en)
|
2020-05-13 |
2024-10-30 |
Edgewise Therapeutics, Inc. |
Pyridazinone compounds for the treatment of neuromuscular diseases
|
|
WO2021231565A1
(en)
|
2020-05-13 |
2021-11-18 |
Edgewise Therapeutics, Inc. |
Pyridazinone compounds for the treatment of neuromuscular diseases
|
|
EP4149467A1
(en)
|
2020-05-13 |
2023-03-22 |
Edgewise Therapeutics, Inc. |
Substituted pyridazinone for use in the treatment of neuromuscular diseases
|
|
EP4149466A1
(en)
|
2020-05-13 |
2023-03-22 |
Edgewise Therapeutics, Inc. |
Substituted pyridazinone for use in the treatment of neuromuscular diseases
|
|
EP4149465A1
(en)
|
2020-05-13 |
2023-03-22 |
Edgewise Therapeutics, Inc. |
Substituted pyridazinone for use in the treatment of neuromuscular diseases
|
|
JP7694135B2
(ja)
|
2021-05-11 |
2025-06-18 |
株式会社大林組 |
接続構造及び接続方法
|
|
EP4433473A1
(en)
|
2021-11-17 |
2024-09-25 |
Edgewise Therapeutics, Inc. |
Pyridazinone compounds and uses thereof
|
|
CN119317621A
(zh)
|
2022-05-11 |
2025-01-14 |
艾知怀斯治疗学公司 |
制备哒嗪酮化合物的方法
|
|
CN120302976A
(zh)
|
2022-09-09 |
2025-07-11 |
艾知怀斯治疗学公司 |
用于治疗神经肌肉病状的哒嗪酮组合物
|